Electrophysiological experiments have demonstrated that gain-of-function mutations in TRPV3 can exert significant pathogenic effects on protein function, leading to the characteristic pathological phenotype of Olmsted syndrome (OS) (7). This evidence concerns the gene TRPV3 and Olmsted syndrome.